Literature DB >> 7790431

Methods for predicting susceptibility of Streptococcus pneumoniae to cefixime.

A L Barry1, P C Fuchs.   

Abstract

Among 698 Streptococcus pneumoniae isolates, 475 were penicillin susceptible and > 99% of those were susceptible to 0.5 microgram of cefixime per ml; other pneumococci were tentatively assumed to be resistant to cefixime. A 1-microgram oxacillin disk was more reliable than a 5-micrograms cefixime disk for predicting susceptibility to cefixime.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7790431      PMCID: PMC228095          DOI: 10.1128/jcm.33.4.1031-1033.1995

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  8 in total

1.  Decreased susceptibility of penicillin-resistant pneumococci to twenty-four beta-lactam antibiotics.

Authors:  J Liñares; T Alonso; J L Pérez; J Ayats; M A Domínguez; R Pallarés; R Martín
Journal:  J Antimicrob Chemother       Date:  1992-09       Impact factor: 5.790

2.  In vitro potency of nine orally administered antimicrobial agents against three respiratory tract pathogens.

Authors:  A L Barry
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-09       Impact factor: 3.267

Review 3.  Treatment and diagnosis of infections caused by drug-resistant Streptococcus pneumoniae.

Authors:  M R Jacobs
Journal:  Clin Infect Dis       Date:  1992-07       Impact factor: 9.079

4.  Screening pneumococci for penicillin resistance.

Authors:  J M Swenson; B C Hill; C Thornsberry
Journal:  J Clin Microbiol       Date:  1986-11       Impact factor: 5.948

Review 5.  Antimicrobial resistance in Streptococcus pneumoniae: an overview.

Authors:  P C Appelbaum
Journal:  Clin Infect Dis       Date:  1992-07       Impact factor: 9.079

6.  In vitro evaluation of cefixime (FK027, FR17027, CL284635): spectrum against recent clinical isolates, comparative antimicrobial activity, beta-lactamase stability, and preliminary susceptibility testing criteria.

Authors:  P C Fuchs; R N Jones; A L Barry; C Thornsberry; L W Ayers; T L Gavan; E H Gerlach
Journal:  Diagn Microbiol Infect Dis       Date:  1986-07       Impact factor: 2.803

7.  In vitro activities of 12 orally administered antimicrobial agents against four species of bacterial respiratory pathogens from U.S. Medical Centers in 1992 and 1993.

Authors:  A L Barry; M A Pfaller; P C Fuchs; R R Packer
Journal:  Antimicrob Agents Chemother       Date:  1994-10       Impact factor: 5.191

8.  Cefixime: spectrum of antibacterial activity against 16,016 clinical isolates.

Authors:  A L Barry; R N Jones
Journal:  Pediatr Infect Dis J       Date:  1987-10       Impact factor: 2.129

  8 in total
  3 in total

1.  Use of an oxacillin disk screening test for detection of penicillin- and ceftriaxone-resistant pneumococci.

Authors:  L P Jetté; C Sinave
Journal:  J Clin Microbiol       Date:  1999-04       Impact factor: 5.948

2.  Surrogate disks for predicting cefotaxime and ceftriaxone susceptibilities of Streptococcus pneumoniae.

Authors:  A L Barry; P C Fuchs
Journal:  J Clin Microbiol       Date:  1996-10       Impact factor: 5.948

Review 3.  Antimicrobial agents for community-acquired respiratory tract infections.

Authors:  A L Barry
Journal:  Infection       Date:  1995       Impact factor: 3.553

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.